These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 27033349)

  • 1. Liposomes as Delivery System of a Sn(IV) Complex for Cancer Therapy.
    Corvo ML; Mendo AS; Figueiredo S; Gaspar R; Larguinho M; Guedes da Silva MF; Baptista PV; Fernandes AR
    Pharm Res; 2016 Jun; 33(6):1351-8. PubMed ID: 27033349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cetuximab-oxaliplatin-liposomes for epidermal growth factor receptor targeted chemotherapy of colorectal cancer.
    Zalba S; Contreras AM; Haeri A; Ten Hagen TL; Navarro I; Koning G; Garrido MJ
    J Control Release; 2015 Jul; 210():26-38. PubMed ID: 25998052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Chimeric Cetuximab-Functionalized Corona as a Potent Delivery System for Microtubule-Destabilizing Nanocomplexes to Hepatocellular Carcinoma Cells: A Focus on EGFR and Tubulin Intracellular Dynamics.
    Poojari R; Kini S; Srivastava R; Panda D
    Mol Pharm; 2015 Nov; 12(11):3908-23. PubMed ID: 26426829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo biological characterization of the anti-proliferative potential of a cyclic trinuclear organotin(iv) complex.
    Martins M; Baptista PV; Mendo AS; Correia C; Videira P; Rodrigues AS; Muthukumaran J; Santos-Silva T; Silva A; da Silva MF; Gigante J; Duarte A; Gajewska M; Fernandes AR
    Mol Biosyst; 2016 Mar; 12(3):1015-23. PubMed ID: 26842219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro characterization of a liposomal formulation of celecoxib containing 1,2-distearoyl-sn-glycero-3-phosphocholine, cholesterol, and polyethylene glycol and its functional effects against colorectal cancer cell lines.
    Erdoğ A; Putra Limasale YD; Keskin D; Tezcaner A; Banerjee S
    J Pharm Sci; 2013 Oct; 102(10):3666-77. PubMed ID: 23897281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological characterization of the antiproliferative potential of Co(II) and Sn(IV) coordination compounds in human cancer cell lines: a comparative proteomic approach.
    Silva A; Luís D; Santos S; Silva J; Mendo AS; Coito L; Silva TF; da Silva MF; Martins LM; Pombeiro AJ; Borralho PM; Rodrigues CM; Cabral MG; Videira PA; Monteiro C; Fernandes AR
    Drug Metabol Drug Interact; 2013; 28(3):167-76. PubMed ID: 23800656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Celastrol-Loaded Galactosylated Liposomes Effectively Inhibit AKT/c-Met-Triggered Rapid Hepatocarcinogenesis in Mice.
    Chen X; Hu X; Hu J; Qiu Z; Yuan M; Zheng G
    Mol Pharm; 2020 Mar; 17(3):738-747. PubMed ID: 31904241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. pH-Sensitive PEGylated liposomes for delivery of an acidic dinitrobenzamide mustard prodrug: Pathways of internalization, cellular trafficking and cytotoxicity to cancer cells.
    Yang MM; Wilson WR; Wu Z
    Int J Pharm; 2017 Jan; 516(1-2):323-333. PubMed ID: 27871834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of cholesterol arabinogalactan anchored liposomes for asialoglycoprotein receptor mediated targeting to hepatocellular carcinoma: In silico modeling, in vitro and in vivo evaluation.
    Pathak P; Dhawan V; Magarkar A; Danne R; Govindarajan S; Ghosh S; Steiniger F; Chaudhari P; Gopal V; Bunker A; Róg T; Fahr A; Nagarsenker M
    Int J Pharm; 2016 Jul; 509(1-2):149-158. PubMed ID: 27231122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antitumour activities induced by pegylated liposomal cytochalasin D in murine models.
    Huang FY; Mei WL; Li YN; Tan GH; Dai HF; Guo JL; Wang H; Huang YH; Zhao HG; Zhou SL; Li L; Lin YY
    Eur J Cancer; 2012 Sep; 48(14):2260-9. PubMed ID: 22257793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased tumor targeted delivery using a multistage liposome system functionalized with RGD, TAT and cleavable PEG.
    Mei L; Fu L; Shi K; Zhang Q; Liu Y; Tang J; Gao H; Zhang Z; He Q
    Int J Pharm; 2014 Jul; 468(1-2):26-38. PubMed ID: 24709209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transporter occluded-state conformation-induced endocytosis: Amino acid transporter ATB
    Luo Q; Gong P; Sun M; Kou L; Ganapathy V; Jing Y; He Z; Sun J
    J Control Release; 2016 Dec; 243():370-380. PubMed ID: 27810556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a liposome-based formulation of oxaliplatin using capillary electrophoresis: encapsulation and leakage.
    Franzen U; Nguyen TT; Vermehren C; Gammelgaard B; Ostergaard J
    J Pharm Biomed Anal; 2011 Apr; 55(1):16-22. PubMed ID: 21282028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PEGylated liposomes modified with LHRH analogs for tumor targeting.
    He Y; Zhang L; Song C
    J Control Release; 2011 Nov; 152 Suppl 1():e29-31. PubMed ID: 22195906
    [No Abstract]   [Full Text] [Related]  

  • 15. Vascular targeting of doxorubicin using cationic liposomes.
    Wu J; Lee A; Lu Y; Lee RJ
    Int J Pharm; 2007 Jun; 337(1-2):329-35. PubMed ID: 17275230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting colon cancer cells using PEGylated liposomes modified with a fibronectin-mimetic peptide.
    Garg A; Tisdale AW; Haidari E; Kokkoli E
    Int J Pharm; 2009 Jan; 366(1-2):201-10. PubMed ID: 18835580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PEGylated liposomes of anastrozole for long-term treatment of breast cancer: in vitro and in vivo evaluation.
    Shavi GV; Sreenivasa Reddy M; Raghavendra R; Nayak UY; Kumar AR; Deshpande PB; Udupa N; Behl G; Dave V; Kushwaha K
    J Liposome Res; 2016; 26(1):28-46. PubMed ID: 25853340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting of pegylated liposomal mitomycin-C prodrug to the folate receptor of cancer cells: Intracellular activation and enhanced cytotoxicity.
    Patil Y; Amitay Y; Ohana P; Shmeeda H; Gabizon A
    J Control Release; 2016 Mar; 225():87-95. PubMed ID: 26809007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Augmented Anticancer Effects of Cantharidin with Liposomal Encapsulation: In Vitro and In Vivo Evaluation.
    Zhang X; Lin CC; Chan WK; Liu KL; Yang ZJ; Zhang HQ
    Molecules; 2017 Jun; 22(7):. PubMed ID: 28672816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RGD peptide conjugated liposomal drug delivery system for enhance therapeutic efficacy in treating bone metastasis from prostate cancer.
    Wang F; Chen L; Zhang R; Chen Z; Zhu L
    J Control Release; 2014 Dec; 196():222-33. PubMed ID: 25456829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.